Technology

 

Study: Emerging AI Platform for DBT Shows 23 Percent Increase in Breast Cancer Detection Rate

March 23, 2023

In a recent video interview, Kathy Schilling, M.D., discussed findings from a study of ProFound AI, an adjunctive artificial intelligence (AI) software for digital breast tomosynthesis (DBT), that demonstrated a 23 percent increase in breast cancer detection in comparison to DBT alone.

Meta-Analysis Finds High Risk of Bias in 83 Percent of AI Neuroimaging Models for Psychiatric Diagnosis

March 17, 2023

In a review of 555 neuroimaging-based artificial intelligence (AI) models for the diagnosis of psychiatric disorders, researchers found that nearly 72 percent of the AI models had an inadequate sample size and over 99 percent were insufficient at handling data complexity.

Gleamer's BoneView Gains FDA Clearance for AI-Powered Pediatric Fracture Detection

March 15, 2023

The artificial intelligence (AI)-enabled software, which has a documented 91 percent sensitivity rate for detecting pediatric fractures, is reportedly the first AI fracture detection modality to receive FDA 510(k) clearance for use in the pediatric population.